Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lexagene Holdings Inc (LXG.VN)

Lexagene Holdings Inc (LXG.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 26,884
  • Shares Outstanding, K 137,866
  • Annual Sales, $ 58 K
  • Annual Income, $ -9,891 K
  • 60-Month Beta 2.04
  • Price/Sales 119.93
  • Price/Cash Flow N/A
  • Price/Book 5.51
Trade LXG.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings -0.02 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Devices

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.175 +11.43%
on 04/20/22
0.240 -18.75%
on 05/02/22
-0.015 (-7.14%)
since 04/13/22
3-Month
0.175 +11.43%
on 04/20/22
0.305 -36.07%
on 02/22/22
-0.105 (-35.00%)
since 02/11/22
52-Week
0.175 +11.43%
on 04/20/22
0.800 -75.63%
on 06/22/21
-0.335 (-63.21%)
since 05/13/21

Most Recent Stories

More News
LexaGene Successfully Completes CRADA with US Army

BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market

BEVERLY, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Announces Closing of Second Tranche of Investment by Strategic Institutional Investor

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- LexaGene...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Announces $6.4 Million Investment by Strategic Institutional Investor

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- LexaGene...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Starts the Year with Additional MiQLab Sales

BEVERLY, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Announces Results of Annual General and Special Meeting

BEVERLY, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Closes Multiple MiQLab Sales

BEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA

BEVERLY, Mass., Nov. 24, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
Leading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of Directors

BEVERLY, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)
LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent

BEVERLY, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene”), a molecular diagnostics company that...

LXG.VN : 0.195 (+2.63%)
LXXGF : 0.1487 (+1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.215
2nd Resistance Point 0.205
1st Resistance Point 0.200
Last Price 0.195
1st Support Level 0.185
2nd Support Level 0.175
3rd Support Level 0.170

See More

52-Week High 0.800
Fibonacci 61.8% 0.561
Fibonacci 50% 0.488
Fibonacci 38.2% 0.414
Last Price 0.195
52-Week Low 0.175

See More

Business Summary

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research,...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar